These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The use of beta agonists and the risk of death and near death from asthma. Pearce N. J Clin Epidemiol; 2009 Jun; 62(6):582-7. PubMed ID: 19422997 [No Abstract] [Full Text] [Related]
5. Re: "Confounding by indication and channeling over time: the risks of beta2-agonists". Pearce N, Beasley R, Crane J, Burgess C. Am J Epidemiol; 1997 Nov 15; 146(10):885-7. PubMed ID: 9384211 [No Abstract] [Full Text] [Related]
10. Fenoterol, asthma deaths, and asthma severity: confounding or confusion? Pearce N, Burgess C, Crane J, Beasley R. Thorax; 1997 Aug 15; 52(8):750-1. PubMed ID: 9337841 [No Abstract] [Full Text] [Related]
11. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity. Garrett JE, Lanes SF, Kolbe J, Rea HH. Thorax; 1996 Nov 15; 51(11):1093-9. PubMed ID: 8958891 [Abstract] [Full Text] [Related]
14. Fenoterol and asthma mortality. Crane J, Pearce N, Burgess C, Beasley R. N Z Med J; 1990 May 09; 103(889):225. PubMed ID: 2342700 [No Abstract] [Full Text] [Related]
15. Fenoterol and asthma mortality. Lipworth B, Jackson C. Lancet; 1998 Aug 08; 352(9126):486-7. PubMed ID: 9708780 [No Abstract] [Full Text] [Related]
16. Fenoterol and asthma mortality. Kremer G, Disse B. Lancet; 1998 Aug 08; 352(9126):485-6. PubMed ID: 9708779 [No Abstract] [Full Text] [Related]
18. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R. Lancet; 1989 Apr 29; 1(8644):917-22. PubMed ID: 2565417 [Abstract] [Full Text] [Related]
19. Fenoterol and severe asthma mortality. N Z Med J; 1989 Jun 14; 102(869):294-7. PubMed ID: 2733905 [No Abstract] [Full Text] [Related]